Clinical
RSSArticles
-
Does a Standardized Recovery Bundle After Cesarean Delivery Decrease Length of Stay?
Implementation of an enhanced recovery bundle after cesarean delivery reflected diverse positive outcomes. However, length of stay was reduced only by an average of two hours.
-
Is RhoGAM Needed for Rh-Negative Women Experiencing First-Trimester Pregnancy Loss or Induced Abortion?
In this prospective cohort pilot study, the authors validated a flow cytometry protocol for detecting fetal red blood cells and determined that fetal red blood cell exposure in first-trimester uterine aspiration was well below the calculated threshold for maternal Rh sensitization.
-
COVID-19 Lockdown Measures May Have Prevented 530 Million Additional Infections
Researchers studied actions taken in six countries and the resulting outcomes.
-
Investigators Identify Connection Between Vascular Malformation, Gut Bacteria Profile
The presence of gram-negative bacteria was linked to an abundance of abnormalities known to cause strokes, seizures, and headaches.
-
Cannabis Use and Stroke Risk: The Debate Continues
A recently published paper suggests there may be no connection, but the conversation on this topic, as well as the general efficacy of medical marijuana, goes on.
-
We'd Love to Hear from You!
Please take five minutes to complete our annual user survey.
-
Study Reveals Low Rate of Contraceptive Use in Women with Recent Preterm Births
Medicaid claims data among a North Carolina cohort show that women were less likely to fill a contraceptive claim within 90 days after preterm birth. Investigators theorized it would be harder for women to access contraception after a preterm birth because they would be caring for a medically fragile infant. Also, women who deliver preterm experience shorter pregnancies, which means there is less time for a conversation with their healthcare providers about contraception.
-
Servicewomen Experience Barriers to Contraception
A follow-up survey of United States servicewomen and their access to contraceptives during their deployment revealed both good and bad news. Some women reported greater access to contraception, while others experienced barriers to obtaining contraceptives in the weeks leading up to their deployment.
-
Study: Copper IUDs Do Not Appear to Prevent Implantation or Increase HIV Risk
For decades, clinicians and the public assumed that copper intrauterine devices (IUDs) prevented pregnancy by preventing implantation. There also was fear that IUDs could increase a woman’s risk of HIV infection. Results of a new study suggested these assumptions are incorrect.
-
Contraceptive Implants Are an Option for Patients Taking Isotretinoin
When clinicians prescribe the acne medication isotretinoin, they advise reproductive-age women to avoid pregnancy through two different contraceptives and an online iPledge app. Since the drug causes severe birth defects, it is important young women do not become pregnant while taking the drug. Etonogestrel contraceptive implants could be one contraceptive option for women taking isotretinoin, but there are concerns the acne drug would decrease the effectiveness of hormonal contraceptives.